Key FDA committee unanimously recommends its first vaccine since 2023
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Key FDA committee unanimously recommends its first vaccine since 2023" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Reuters, PBS, Yahoo Finance and Dallas News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 45d ago.
Quick answers
Why is "Key FDA committee unanimously recommends its first vaccine since 2023" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine Yahoo Finance · 45d ago
- FDA committee unanimously recommends first mRNA flu vaccine NPR · 45d ago
- Moderna's mRNA flu vaccine backed by FDA advisers Reuters · 45d ago
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology PBS · 45d ago
- Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine Yahoo Finance · 45d ago
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology Dallas News · 45d ago
Topics
Related trends
FDA Panel Backs 6 Peptides for Compounding
An FDA advisory panel has voted to ease restrictions on six peptides for compounding, sparking a debate between regulators, scientists, and political figures.
Nearly 12 million bottles of Rohto eye drops over sterility concerns, FDA announces
The FDA announces a recall of nearly 12 million bottles of Rohto eye drops due to sterility concerns.
Fruit sold at Publix sickens multiple people in 8 states
Publix has expanded a multi-state recall of frozen berries after an E. coli outbreak sickened 12 people across eight states.
Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New, more efficient pill to lower cholesterol
FDA approves first oral PCSK9 inhibitor for adults with high cholesterol, changing treatment options.
FDA Panel Votes In Favor of Replimune’s Melanoma Treatment
Replimune shares surge following a favorable FDA advisory panel vote for its melanoma treatment.